Beranda › Gagal Jantung › Missouri › St. Louis
Uji klinis Gagal Jantung di St. Louis, MO
26 studi untuk Gagal Jantung mencari peserta di lokasi sekitar St. Louis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Menerima pesertaFase 3
- St. Louis Heart and Vascular, P.C., St Louis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Menerima pesertaFase 3
- St. Louis Heart and Vascular, P.C., St Louis
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Menerima pesertaFase 2
- Washington University School of Medicine, St Louis
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Menerima pesertaFase 3
- Research Site, Bridgeton · 15 mi jauhnya
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Menerima pesertaFase 3
- Washington University Center for Advanced Medicine, St Louis
A Study of LY3971297 in Participants With Heart Failure
Menerima pesertaFase 1
- Washington University, St Louis
Alleviant ALLAY-HFrEF Study
Menerima peserta
- Washington University - St Louis, St Louis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Menerima pesertaFase 3
- Research Site, St Louis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Menerima peserta
- WashU Medicine, St Louis
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Menerima pesertaFase 2
- Local Institution - 109, St Louis
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Menerima pesertaFase 2/3
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Menerima pesertaFase 2
- Washington University Center for Advanced Medicine, St Louis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Menerima pesertaStudi observasional
- St Louis, St Louis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Menerima pesertaStudi observasional
- Washington University, St Louis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Menerima pesertaFase 3
- Tenax Investigational Site, St Louis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
Alleviant ALLAY-HF Study
Menerima peserta
- Washington University - St Louis, St Louis
Assessment of CCM in HF With Higher Ejection Fraction
Menerima peserta
- St. Louis Heart and Vascular, Bridgeton · 15 mi jauhnya
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Menerima pesertaFase 3
- Washington Univ School Of Medicine, St Louis
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
Menerima pesertaFase 2
- Washington University School of Medicine, St Louis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Menerima peserta
- St. Louis Heart and Vascular, St Louis
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Menerima pesertaFase 3
- Washington University, St Louis
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Menerima peserta
- Washington University - Barnes Jewish Health Hospital, St Louis
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Menerima pesertaFase 1/2
- Washington University in Saint Louis, St Louis
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- Durham, NC26 studi
- Atlanta, GA25 studi
- Kansas City, MO25 studi
- Baltimore, MD24 studi
Studi lain di St. Louis
- Kanker Paru Non-Sel Kecil73 studi
- Kanker Payudara64 studi
- Kanker Metastatik54 studi
- Kanker Kolorektal50 studi
- Kanker Prostat46 studi
- Kanker (semua jenis)46 studi
- Kanker Paru39 studi
- Kanker Ovarium38 studi
- Kanker Pankreas33 studi
- Kanker Endometrium29 studi
- Karsinoma Sel Skuamosa Kepala dan Leher28 studi
- Obesitas25 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.